Your browser doesn't support javascript.
loading
Effect of angiotensin-converting enzyme inhibitors and receptor blockers on appropriate implantable cardiac defibrillator shock in patients with severe systolic heart failure (from the GRADE Multicenter Study).
AlJaroudi, Wael A; Refaat, Marwan M; Habib, Robert H; Al-Shaar, Laila; Singh, Madhurmeet; Gutmann, Rebecca; Bloom, Heather L; Dudley, Samuel C; Ellinor, Patrick T; Saba, Samir F; Shalaby, Alaa A; Weiss, Raul; McNamara, Dennis M; Halder, Indrani; London, Barry.
Afiliação
  • AlJaroudi WA; Division of Cardiovascular Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Refaat MM; Division of Cardiovascular Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: mr48@aub.edu.lb.
  • Habib RH; Department of Internal Medicine, Outcomes Research Unit, Beirut, Lebanon; Vascular Medicine Program, American University of Beirut Medical Center, Beirut, Lebanon.
  • Al-Shaar L; Department of Internal Medicine, Outcomes Research Unit, Beirut, Lebanon; Vascular Medicine Program, American University of Beirut Medical Center, Beirut, Lebanon.
  • Singh M; Division of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
  • Gutmann R; Division of Cardiovascular Medicine, University of Iowa Carver College of Medicine, Iowa City, IA.
  • Bloom HL; Division of Cardiology, Emory University School of Medicine, Atlanta, GA.
  • Dudley SC; Division of Cardiology, The Warren Alpert Medical School of Brown University, Providence, RI.
  • Ellinor PT; Division of Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA.
  • Saba SF; Division of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
  • Shalaby AA; Division of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, PA; Cardiology Division, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA.
  • Weiss R; Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH.
  • McNamara DM; Division of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
  • Halder I; Division of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
  • London B; Division of Cardiovascular Medicine, University of Iowa Carver College of Medicine, Iowa City, IA.
Am J Cardiol ; 115(7): 924-31, 2015 Apr 01.
Article em En | MEDLINE | ID: mdl-25682436

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Enzima Conversora de Angiotensina / Medição de Risco / Insuficiência Cardíaca Sistólica / Antagonistas de Receptores de Angiotensina Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Am J Cardiol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Líbano País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Enzima Conversora de Angiotensina / Medição de Risco / Insuficiência Cardíaca Sistólica / Antagonistas de Receptores de Angiotensina Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Am J Cardiol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Líbano País de publicação: Estados Unidos